Intesa Sanpaolo Launches €30.6 Billion Bid for Monte dei Paschi to Drive Italian Banking Consolidation 
Honda Leadership Crisis Deepens as Retired Executives Challenge CEO Toshihiro Mibe’s Strategy 
Apple Unveils Enhanced Apple Intelligence and Next-Generation Siri at WWDC 2026 
Astera Labs and Rocket Lab Surge After Nasdaq-100 Inclusion Announcement 
Naver Stock Jumps on NVIDIA Partnership to Build South Korea’s AI Infrastructure 
Coupang Hit With Record $409 Million Fine Over Data Breach Affecting 33 Million Users 
SpaceX IPO Sets Record With $75 Billion Raise, Valuation Hits $1.77 Trillion 
EngineAI Files for Hong Kong IPO Amid Rising Demand for AI and Robotics Stocks 
Woodside Energy Acquires PetroChina’s Browse Stake, Expands Position in Major Australian Gas Project 
Wizz Air Beats Profit Forecast as Cost Controls Offset Industry Challenges 
Alibaba Offers $1.5 Billion to Acquire Grocery Delivery Platform Pupu 
BHP Port Hedland Workers Back Strike Action Amid Pay Dispute 
J.P. Morgan Sees Major Upside for Prysmian as Optical Fiber Prices Surge 
Meta Partners With Reliance to Launch First AI-Powered Data Center in India 
GM and Peak Energy Partner to Advance Sodium-Ion Battery Technology for Grid Storage 
Qualcomm Stock Gains After Jensen Huang Endorsement 
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent 
Kolmar Korea, a Sejong City-headquartered pharmaceutical preparation manufacturing company, surpassed KRW2 trillion in annual sales for the first time since its founding in 1995. The company reached this milestone due to the immense growth of its subsidiary in China.
The company is looking to expand its market in the United States and will focus on its sunscreen products for this goal. Kolmar Korea can realize this plan as it has already laid the foundations for scaling up its business in the American market.
Targeting Bigger Market Share in the US
As per The Korea Times, Kolmar Korea is speeding up its market expansion in the U.S. market with its sunscreen products. The company prepared for this by obtaining product certification and setting up a new research and development center (R&D).
Kolmar Korea established the facility to better analyze the local consumer market and work on what is best to grow and expand to other regions. The company's primary target today is boosting the sales and demand for its sunscreen in the country since this will equate to success.
It was reported that the largest sunscreen developer in the country is targeting the U.S. because it has the most expansive market for sunscreens.
Big Sucess in China
Meanwhile, as it aims for U.S. expansion, the company is doing well in China. It hit KRW2 trillion in annual sales for the first time. Korea's Consumer News reported that Kolmar Korea said the main reason for the surge in sales was the growth of small and medium-sized indie brands in the country.
It was noted that the firm's ODM (Original Design Manufacturing) and OEM (Original Equipment Manufacturing) are remarkable and played prominent roles in raking in big sales in the territory. Kolmar Korea's Chinese subsidiary also accounts for the second-highest sales share after Korea, so the brand achieved a good performance in 2023.
"A potential for growth in the North American market, including the U.S., is limitless as sunscreen functions are incorporated not only in sunscreens but also in BB creams and foundations," a company official stated. "We plan to actively target the U.S., the world's No. 1 beauty market, not content with just holding a 70 percent share in the domestic sunscreen product market."
Photo by: Kolmar Website
